STX209 therapy is a molecular approach to restore neurological connections in Fragile X cases. The new molecular approach corrects the disease rather than mask the symptoms. The Reading Room provides additional information about the latest autism therapies.
No standardized treatments exist for individuals diagnosed with autism spectrum disorder (ASD). Instead, treatment strategies vary based on the type and severity of symptom presentation.
It’s important to consider that not all therapies are equal. While some treatment options have been tested in well-designed studies (evidence-based), others are only now emerging. Some of these are well established (evidence-based) while others maybe promising or emerging therapeutics requiring further assessment of its clinical utility.